ALPS Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

ALPS Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-25,586	Closed	-$1.93M	–	833
2015 Q2	$1.93M	Buy	25,586 +14,342	+128%	+$768K	0.02%	171
2015 Q1	$564K	Buy	+11,244	New	+$472K	﹤0.01%	255

Other funds holding KYTH

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

ALPS Advisors's KYTH Position: Q3 2015 in Review

ALPS Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 25,586 shares — an estimated $1.93M sold.

ALPS Advisors first reported a position in KYTH in Q1 2015 and held it in 2 quarters. The position peaked at $1.93M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

ALPS Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
ALPS Advisors sold 25,586 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $1.93M.
ALPS Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2015 and held it in 2 quarters.
ALPS Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.93M in Q2 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on ALPS Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.